|
- 2018
PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapyDOI: 10.1080/2162402X.2018.1507600 Keywords: Synovial sarcoma, HLA Class I, PRAME, T-cell infiltration, TCR-gene therapy Abstract:
|